Search
Protagonist Therapeutics Inc
PTGXAdd to Watchlist
132.040USD
-3.220-2.38%
Close 11-06 16:00（ET）
8.54BMarket Cap
LossP/E TTM
Today
-2.38%
5 Days
-8.84%
1 Month
-4.79%
6 Months
+27.00%
Year to Date
+51.18%
1 Year
+65.51%
Key Figures
135.260Open
138.395High
46.17KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
135.260Prev. Close
128.000Low
6.08MTurnover
31.03P/E Static
10.15P/B
0.00%Div Yield TTM
-15.94%ROA
160.81052wk High
0.08Volume Ratio
275.19MNet Profit
64.71MShares
-1.8040EPS TTM
1.86Beta
-17.06%ROE
77.00052wk Low
11.25%Amplitude
100.00%Gross Margin
8.54BMarket Cap
4.97Reward/Risk
2.54%Risk Rate
More news coming soon, stay tuned...
Protagonist Therapeutics Inc's Score
-0.02vs previous score
Forecast8.71
Financial Health9.31
Technical3.81
Valuation Dimensions7.21
Institutional Confidence10.00
Risk Assessment6.64
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Protagonist Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
2.47/2.08
Revenue / Forecast
213.47M/203.76M
Protagonist Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolPTGX
Number of employees126
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 12.94% |
| Farallon Capital Management, L.L.C. | 9.55% |
| UBS Financial Services, Inc. | 7.88% |
| RTW Investments L.P. | 7.87% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 41.53% |
| Investment Advisor | 41.38% |
| Hedge Fund | 19.80% |
| Venture Capital | 3.81% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Protagonist Therapeutics Inc (PTGX)?
The current price of Protagonist Therapeutics Inc (PTGX) is 132.04.
What is the symbol of Protagonist Therapeutics Inc?
The ticker symbol of Protagonist Therapeutics Inc is PTGX.
What is the 52-week high of Protagonist Therapeutics Inc?
The 52-week high of Protagonist Therapeutics Inc is 160.81.
What is the 52-week low of Protagonist Therapeutics Inc?
The 52-week low of Protagonist Therapeutics Inc is 77.00.
What is the market capitalization of Protagonist Therapeutics Inc?
The market capitalization of Protagonist Therapeutics Inc is 8.54B.
Is Protagonist Therapeutics Inc (PTGX) currently rated as Buy, Hold, or Sell?
According to analysts, Protagonist Therapeutics Inc (PTGX) has an overall rating of Buy, with a price target of 179.43.
What is the Earnings Per Share (EPS TTM) of Protagonist Therapeutics Inc (PTGX)?
The Earnings Per Share (EPS TTM) of Protagonist Therapeutics Inc (PTGX) is -1.80.